{"result": {"id": "chatcmpl-117", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Cancer Research Community\",\n    \"summary\": \"This community focuses on cancer research, particularly its impact on angiogenesis and treatment strategies. It explores various entities like pro-coagulation genes, bevacizumab, and the role of β-caten in tumor growth. The community highlights the connection between coagulation factors, disease progression, and potential therapeutic targets.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The community's focus on cancer research, its impact on angiogenesis, and the exploration of specific entities like pro-coagulation genes and bevacizumab suggests a significant level of influence and potential for impactful discoveries.\",\n    \"findings\": [\n        {\n            \"summary\": \"Pro-coagulant gene expression is linked to worse prognosis in cancer patients.\",\n            \"explanation\": \"The community highlights the connection between pro-coagulation genes, increased intra-tumoral angiogenesis, and poorer patient outcomes. This suggests that targeting these genes could be a promising avenue for improving treatment efficacy.  For example, higher expression of pro-coagulant genes is associated with worse disease-specific survival in TCGA cohort. The study also shows that patients with high coagulation scores had worse overall survival in the TCGA cohort. These findings suggest that inhibiting pro-coagulation pathways could be a valuable strategy for cancer treatment.\"\n        },\n        {\n            \"summary\": \"Bevacizumab, an anti-angiogenic drug, is being investigated as a potential treatment option for endometrial cancers.\",\n            \"explanation\": \"The community explores the use of bevacizumab in treating endometrial cancers. This drug targets angiogenesis, which plays a crucial role in tumor growth and progression. The study suggests that bevacizumab may hold promise for improving patient outcomes.  For example, the community highlights the potential of bevacizumab to improve treatment efficacy in endometrial cancer patients.\"\n        },\n        {\n            \"summary\": \"β-caten is a target of bevacizumab and plays a role in tumor growth.\",\n            \"explanation\": \"The community explores the connection between β-caten, a key protein involved in cell signaling, and bevacizumab's mechanism of action.  Bevacizumab targets β-caten to inhibit angiogenesis. This finding suggests that targeting β-caten could be a valuable strategy for cancer treatment.\"\n        },\n        {\n            \"summary\": \"The TCGA study provides insights into the relationship between coagulation factors and cancer prognosis.\",\n            \"explanation\": \"The TCGA (The Cancer Genome Atlas) study offers valuable data on the connection between coagulation factors, intra-tumoral angiogenesis, and patient outcomes.  For example, patients with high coagulation scores had worse disease-specific survival in the TCGA cohort. This suggests that targeting coagulation pathways could be a promising avenue for improving treatment efficacy.\"\n        },\n        {\n            \"summary\": \"The GSE84437 study provides evidence of the link between pro-coagulant genes and angiogenesis.\",\n            \"explanation\": \"The GSE84437 study further supports the connection between pro-coagulant genes, intra-tumoral angiogenesis, and patient outcomes.  For example, higher expression of pro-coagulant genes is associated with worse disease-specific survival in the GSE84437 study.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743185221, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 706, "prompt_tokens": 2048, "total_tokens": 2754, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n3269,PDAC,\"The **PDAC** (Pancreatic ductal adenocarcinoma) is a type of cancer that affects the cells lining the pancreatic ducts.  Researchers study PDAC to understand its development and potential treatments. \n\",10\n3270,MIR-210,\"The **MIR-210** microRNA is a type of microRNA (miRNA) that plays a significant role in the development and progression of pancreatic ductal adenocarcinoma (PDAC). It is found within exosomes, tiny vesicles released by cells.  Specifically, MIR-210 is abnormally expressed in the exosomes of PDAC patients, suggesting its involvement in tumor growth. This microRNA has been identified as a potential target for therapeutic interventions aimed at inhibiting tumor progression. \n\",2\n3271,MICROARRAY STUDIES,,1\n3277,EFNA3,Protein involved in tumor angiogenesis and cell invasion,1\n3278,PI3K/AKT/VEGFA,Pathway involved in tumor angiogenesis,1\n3279,WNT/Β-CATENIN/RHOA,Pathway involved in tumor angiogenesis,1\n3282,VASCULAR INVASION,,1\n3283,TNM STAGE,,1\n198,TCGA,\"The **TCGA** (The Cancer Genome Atlas) is a comprehensive database of cancer data. It encompasses various aspects of cancer research, including gene expression analysis, clinical data on patient cohorts, and genomic data from cancer patients.  Specifically, the TCGA dataset includes information about PAAD patients, glioma, and HCC, serving as a valuable resource for analyzing differentially expressed ARGs (Alterations in Gene Expression) in these cancers. The TCGA database is also known as \"\"The Cancer Genome Atlas\"\" and \"\"TCGA dataset,\"\" highlighting its significance in cancer research. \n\",5\n1171,PRO-COAGULATION GENES,Genes associated with increased coagulation and tumor growth,4\n1174,OVERALL SURVIVAL,,3\n1169,GSE84437,\"The **GSE84437** cohort is a database containing gastric cancer patient data. This dataset, also known as a cohort, is part of the larger GSE84437 study. \n\",4\n1513,ENDOMETRIAL CANCER,\"Endometrial cancer is a type of gynecologic malignancy that is on the rise. \n\",3\n1514,BEVACIZUMAB,\"**Bevacizumab** is a monoclonal antibody (mAb) used as an anti-angiogenesis drug. It is primarily used to treat various cancers, including hepatocellular carcinoma (HCC), and has been approved for the treatment of central serous chorioretinopathy. Bevacizumab inhibits angiogenesis, which is the formation of new blood vessels, by targeting specific proteins involved in this process.  It can be used in clinical settings to starve tumors and inhibit their growth. \n\nWhile it's primarily known for its use in cancer treatment, Bevacizumab has also been studied for its potential in treating other conditions like MNV (multiple myeloma) and CNV (central nervous system). It is important to note that Bevacizumab can cause cardiovascular adverse events (AEs), which are most frequently reported. \n\",5\n1608,PDX,Mouse model for studying cancer,3\n1172,DISEASE-SPECIFIC SURVIVAL,,2\n1176,COAGULATION SCORES,Coagulation scores in patients,2\n1516,Β-CATEN,,1\n1523,GOG-86P,Clinical trial investigating bevacizumab response in CTNNB1-mutated ECs,1\n1173,WORSE DISEASE-SPECIFIC SURVIVAL,,1\n1175,WORSE OVERALL SURVIVAL,,1\n1607,SCID,Type of mice used in the experiment,2\n1515,CPTAC,Protein expression database,1\n1609,ANTIANGIOGENIC DRUG,,2\n5331,EA-EXO,\"The **EA-EXO** is a type of extracellular vesicle that plays a role in inducing angiogenesis. It is also a type of protein expression system. \n\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n1319,PDAC,EXOSOMES,PDAC exosomes are a source of miRNAs,21\n1329,MIR-210,PDAC,miR-210 is found in PDAC cells and promotes PDAC progression,12\n1321,PDAC,MICROARRAY STUDIES,Microarray studies were used to detect aberrantly expressed miRNAs in PDAC exosomes,11\n1324,PDAC,EFNA3,EFNA3 negatively regulated by miR-210,11\n1325,PDAC,PI3K/AKT/VEGFA,miR-210 promotes tumor angiogenesis via PI3K/AKT/VEGFA pathway,11\n1326,PDAC,WNT/Β-CATENIN/RHOA,miR-210 promotes tumor angiogenesis via Wnt/β-catenin/RhoA pathway,11\n1330,PDAC,VASCULAR INVASION,PDAC cell-secreted exosomes promote angiogenesis and vascular invasion,11\n1331,PDAC,TNM STAGE,Exosomal miR-210 expression was high and significantly associated with TNM stage,11\n451,TCGA,PRO-COAGULATION GENES,Higher expression of pro-coagulation genes correlated with increased intra-tumoral angiogenesis in TCGA study,9\n453,TCGA,OVERALL SURVIVAL,Patients with high coagulation scores had worse overall survival in TCGA cohort,8\n455,GSE84437,PRO-COAGULATION GENES,Higher expression of pro-coagulation genes correlated with increased intra-tumoral angiogenesis in GSE84437 study,8\n615,ENDOMETRIAL CANCER,BEVACIZUMAB,Endometrial cancers may respond to bevacizumab treatment,8\n650,PDX,BEVACIZUMAB,Bevacizumab was used to treat PDX mice,8\n452,TCGA,DISEASE-SPECIFIC SURVIVAL,Patients with high coagulation scores had worse disease-specific survival in TCGA cohort,7\n454,TCGA,COAGULATION SCORES,Patients with high coagulation scores had worse disease-specific and overall survival in TCGA cohort,7\n618,BEVACIZUMAB,Β-CATEN,β-caten is a target of bevacizumab treatment,6\n623,GOG-86P,BEVACIZUMAB,Clinical trial investigating bevacizumab response in CTNNB1-mutated ECs,6\n459,PRO-COAGULATION GENES,WORSE DISEASE-SPECIFIC SURVIVAL,Higher expression of pro-coagulation genes correlated with worse disease-specific survival,5\n460,PRO-COAGULATION GENES,WORSE OVERALL SURVIVAL,Higher expression of pro-coagulation genes correlated with worse overall survival,5\n648,SCID,PDX,Mice used in the experiment were PDX mice,5\n617,ENDOMETRIAL CANCER,CPTAC,CPTAC data was used to identify potential targets for β-caten,4\n649,SCID,ANTIANGIOGENIC DRUG,SCID mice are used in the study of antiangiogenic drugs,4\n2434,EA-EXO,MIR-210,EA-EXO miR-210 promotes angiogenesis in hypoxia conditions via HIF-1α/VEGF/Notch 1 signal pathway,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_b2ea5a9686f86fa81d17040ef9aa780e77574fd8fd843184bae704b7a40ead12_v2"}